Simulations Plus (SLP) Revenue (2010 - 2026)
Simulations Plus (SLP) revenue from Nov 30, 2010 to May 31, 2026. The TTM Simulations Plus (SLP) revenue is $82M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Simulations Plus (SLP) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2.10% |
| 3 Years TTM | +13.81% |
| 5 Years TTM | +17.51% |
| 10 Years TTM | +15.32% |
| All Time TTM | +16.52% |
Annual Revenue change of Simulations Plus (SLP)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $46M | -41.68% |
| 2025 | $79M | +13.10% |
| 2024 | $70M | +17.51% |
| 2023 | $60M | +10.52% |
| 2022 | $54M | +16.01% |
| 2021 | $46M | +11.73% |
| 2020 | $42M | +342.45% |
| 2019 | $9.40M | +24.67% |
| 2018 | $7.54M | +6.65% |
| 2017 | $7.07M | +30.44% |
| 2016 | $5.42M | +11.98% |
| 2015 | $4.84M | -57.77% |
| 2014 | $11M | +13.80% |
| 2013 | $10M | +6.56% |
| 2012 | $9.45M | +8.12% |
| 2011 | $8.74M | +326.34% |
| 2010 | $2.05M | N/A |
Comparison Simulations Plus (SLP) five years revenue CAGR with competitors
Simulations Plus (SLP) five years revenue CAGR is 10.90%.
| Ticker | Name | five years Revenue CAGR | Upside |
|---|---|---|---|
| FORA | Forian Inc | 70.29% | +544.98% |
| LFMD | LifeMD Inc | 30.45% | +179.38% |
| TALK | Talkspace Inc | 25.62% | +135.13% |
| DOCS | Doximity Inc - Class A | 25.53% | +134.26% |
| PHR | Phreesia Inc | 24.17% | +121.79% |
| PRVA | Privia Health Group Inc | 22.40% | +105.55% |
| SOPH | SOPHiA Genetics SA | 22.12% | +102.94% |
| TDOC | Teladoc Health Inc | 18.11% | +66.19% |
| OPRX | OptimizeRx Corp | 17.98% | +65.01% |
| SDGR | Schrodinger Inc | 17.45% | +60.14% |
| DRIO | DarioHealth Corp | 17.39% | +59.62% |
| VEEV | Veeva Systems Inc - Class A | 16.28% | +49.37% |
| EVH | Evolent Health Inc - Class A | 16.18% | +48.46% |
| TXG | 10x Genomics Inc - Class A | 13.93% | +27.84% |
| HQY | Healthequity Inc | 12.94% | +18.73% |
| CERT | Certara Inc | 10.67% | -2.06% |
| HCAT | Health Catalyst Inc | 8.67% | -20.42% |
| GDRX | GoodRx Holdings Inc - Class A | 6.40% | -41.25% |
| OMCL | Omnicell Inc | 6.02% | -44.71% |
| TBRG | TruBridge Inc | 5.65% | -48.12% |
| HSTM | Healthstream Inc | 4.79% | -56.03% |
| ZCMD | Zhongchao Inc - Class A | 4.43% | -59.35% |
| CCLD | CareCloud Inc | 3.38% | -68.97% |
| CCLDO | CareCloud Inc | 3.38% | -68.97% |
| SY | So-Young International Inc | 3.30% | -69.70% |
| CTEV | MultiPlan Corp - Class A | 0.80% | -92.67% |
| NRC | National Research Corp | 0.55% | -94.94% |